Roivant Sciences Ltd.

NASDAQ: ROIV · Real-Time Price · USD
11.62
0.22 (1.93%)
At close: Jun 26, 2025, 3:59 PM
11.60
-0.13%
After-hours: Jun 26, 2025, 07:57 PM EDT

Roivant Sciences Revenue Breakdown

Period Ending Mar 31, 2024 Mar 31, 2023
Product Revenue 75.06M 28.01M
Product Revenue Growth +167.96% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Selling, General, and Administrative Revenue 99.56M 141.54M 201.79M 148.52M 169.62M 197.28M 164.35M 156.19M 120.3M 163.52M
Selling, General, and Administrative Revenue Growth -29.66% -29.85% +35.87% -12.44% -14.02% +20.03% +5.23% +29.83% -26.43% n/a
Research and Development Revenue 133.26M 141.59M 142.35M 133.21M 120.9M 123.72M 131.98M 125.13M 131.86M 125.53M
Research and Development Revenue Growth -5.89% -0.53% +6.86% +10.18% -2.28% -6.26% +5.47% -5.10% +5.04% n/a
Sales and Marketing Revenue 1.09M n/a -1.09M n/a n/a n/a n/a 156.19M n/a n/a
Sales and Marketing Revenue Growth n/a -100.00% n/a n/a n/a n/a -100.00% n/a n/a n/a